Recombinant Newcastle Disease Virus Anhinga Strain and TRAIL Protein Cooperate to Kill Cancer Cells in Culture

HAO Jing-Bo,WANG Wen-Fei,WU Yun-Zhou,LIU Ming-Yao,GAO Zhen-Qiu,ZHANG Qiao,YAN Shi-Jun,LI De-Shan

DOI: https://doi.org/10.13865/j.cnki.cjbmb.2011.01.017

2011-01-01

Abstract:The plasmid containing the full-length cDNA from Newcastle disease virus(NDV) Anhinga strain was cotransfected with helper plasmids encoding viral nucleoprotein,phosphoprotein and large polymerase protein into BSR T7 /5 cells stably expressing the T7 RNA polymerase.The recombinant virus was rescued and amplified by inoculation of the supernatant from the transfected cells into the allantoic cavity of specific-pathogen free chicken embryos.By reverse transcriptase-PCR(RT-PCR),restriction digestion and sequencing confirmation,the success of the rescue process was confirmed by identification of the unique molecular tag of the rescued virus.We also measured virus hemagglutination(HA) titer through the hemagglutination test(HA test),and determined viral titers by plaque-formation units.Thus,we conclude that the virus was rescued successfully from the cDNA.We evaluated the cancer therapeutic potential of the rescued NDV in tumor cells,SH-SY5Y,A549,SMMC-7721 and HepG2 cells.Our data showed that the recombinant NDV could induce apoptosis in A549 and SMMC-7721 cells,and induce necrosis in SH-SY5Y and HepG-2 cells.The inhibitory effects of the recombinant virus on growth of the tumor cells could be enhanced by treatment with Trail,a TNF family member.